In line with these observations, our rescue assays demonstrated that CD44 depletion markedly hindered the promoting role of CALCR in RCC cell growth, migration and anti-apoptosis, emphasizing the essential involvement of CD44 in CALCR-driven RCC progression. The gene discussed is CD44; the disease is renal cell carcinoma.